Progressive multifocal leukoencephalopathy

Results: 49



#Item
1www.edoriumjournals.com CASE REPORT PEER REVIEWED | OPEN ACCESS

www.edoriumjournals.com CASE REPORT PEER REVIEWED | OPEN ACCESS

Add to Reading List

Source URL: www.ijcasereportsandimages.com

Language: English - Date: 2015-12-29 10:43:50
22 Research news PML case reported for dimethyl fumarate (Tecfidera) A case of progressive multifocal leukoencephalopathy (PML) has been reported in a person who had been taking dimethyl fumarate. The person, who subsequ

2 Research news PML case reported for dimethyl fumarate (Tecfidera) A case of progressive multifocal leukoencephalopathy (PML) has been reported in a person who had been taking dimethyl fumarate. The person, who subsequ

Add to Reading List

Source URL: www.mstrust.org.uk

Language: English - Date: 2015-01-22 06:34:52
    3by Nancy Wongvipat, M.P.H. he first HAART treatments, in 1996, included a protease inhibitor along with two nucleoside analog drugs to

    by Nancy Wongvipat, M.P.H. he first HAART treatments, in 1996, included a protease inhibitor along with two nucleoside analog drugs to

    Add to Reading List

    Source URL: img.thebody.com

    Language: English - Date: 2006-09-17 23:24:45
    4AIDS Research and Therapy BioMed Central Open Access

    AIDS Research and Therapy BioMed Central Open Access

    Add to Reading List

    Source URL: www.aidsrestherapy.com

    Language: English
    5Kwartaalbericht 4e kwartaalnovember 2012 Contents

    Kwartaalbericht 4e kwartaalnovember 2012 Contents

    Add to Reading List

    Source URL: www.lareb.nl

    Language: English
    6Coelho et al. Virology Journal 2010, 7:42 http://www.virologyj.com/contentHYPOTHESIS Open Access

    Coelho et al. Virology Journal 2010, 7:42 http://www.virologyj.com/contentHYPOTHESIS Open Access

    Add to Reading List

    Source URL: www.virologyj.com

    Language: English
    7Dimethyl fumarate linked to development of PML

    Dimethyl fumarate linked to development of PML

    Add to Reading List

    Source URL: medicalxpress.com

    Language: English - Date: 2015-05-03 11:02:40
    8Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium IMI Work Package 5: Supplement 2 to Wave 1 Case Study Report 1:b:iii: Efalizumab Multi-Criteria Decision Analysis: Decision

    Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium IMI Work Package 5: Supplement 2 to Wave 1 Case Study Report 1:b:iii: Efalizumab Multi-Criteria Decision Analysis: Decision

    Add to Reading List

    Source URL: protectbenefitrisk.eu

    Language: English - Date: 2014-07-16 01:09:14
    9Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium IMI PROTECT WP5 IMI Report 2:b:iv NATALIZUMAB WAVE 2 CASE STUDY REPORT Review of methodologies for benefit and

    Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium IMI PROTECT WP5 IMI Report 2:b:iv NATALIZUMAB WAVE 2 CASE STUDY REPORT Review of methodologies for benefit and

    Add to Reading List

    Source URL: protectbenefitrisk.eu

    Language: English - Date: 2014-07-16 01:09:14
    10Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium IMI Work Package 5: Report 1:b:iii Benefit - Risk Wave 1 Case Study Report: Raptiva® (efalizumab)

    Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium IMI Work Package 5: Report 1:b:iii Benefit - Risk Wave 1 Case Study Report: Raptiva® (efalizumab)

    Add to Reading List

    Source URL: protectbenefitrisk.eu

    Language: English - Date: 2014-07-16 01:09:12